Journal of Cancer Research and Therapeutics Close
 

Figure 4: Adenocarcinoma NOS, moderately differentiated (a, H and E), negative p21 expression (b) high Ki67 expression (c) and (×40)

Figure 4: Adenocarcinoma NOS, moderately differentiated (a, H and E), negative p21 expression (b) high Ki67 expression (c) and (×40)